North American Pharmaceutical/Biotech Industry Expects Robust Capital Construction Activity in First Half of 2020, an Industrial Info Market Brief
North American Pharmaceutical/Biotech Industry Expects Robust Capital Construction Activity in First Half of 2020, an Industrial Info Market Brief
Attachment: Pharma
The Pharmaceutical & Biotech Industry outlook remains strong for the first half of 2020. Industrial Info's Pharma/Bio group is tracking nearly 360 major capital construction projects with a total investment value (TIV) of $14.4 billion set for kickoff in this time frame. The U.S. northeast region leads in expenditures, followed by the southeast and New England regions.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021